Compounds > 2-(2-methoxyethoxy)ethyl methacrylate
Page last updated: 2024-12-08
2-(2-methoxyethoxy)ethyl methacrylate
Description
## 2-(2-Methoxyethoxy)ethyl methacrylate (MEO2MA)
**2-(2-Methoxyethoxy)ethyl methacrylate** (also known as **methoxy polyethylene glycol methacrylate**) is a **monomeric compound** that belongs to the **methacrylate** family. It's a clear, colorless liquid that's soluble in organic solvents.
**Here's why it's important for research:**
* **Versatile monomer:** MEO2MA is a versatile monomer that can be **polymerized** (joined together to form long chains) using various methods. This allows researchers to create a wide range of **polymers** with specific properties.
* **Hydrophilic properties:** MEO2MA incorporates a **polyethylene glycol (PEG) chain**, which imparts **hydrophilicity** (affinity for water) to the polymer. This makes it suitable for applications in:
* **Biomaterials:** MEO2MA-based polymers can be used in **drug delivery systems**, **tissue engineering scaffolds**, and **biocompatible coatings** due to their water-soluble nature.
* **Coatings:** They can also be used in **antifouling coatings** for medical devices and surfaces, preventing unwanted biological interactions.
* **Controllable properties:** By varying the **molecular weight** and **composition** of the MEO2MA-based polymers, researchers can control their properties like:
* **Solubility**
* **Biodegradability**
* **Mechanical strength**
* **Biocompatibility**
**Applications in research:**
* **Drug delivery:** MEO2MA-based polymers can encapsulate drugs and release them in a controlled manner at specific locations in the body.
* **Tissue engineering:** They can be used to create 3D scaffolds that support cell growth and tissue regeneration.
* **Biomedical devices:** MEO2MA polymers can be used to create coatings for implants, catheters, and other devices to enhance their biocompatibility and prevent infection.
* **Coatings:** MEO2MA-based coatings can be applied to surfaces to make them hydrophilic, resistant to fouling, and easy to clean.
**Overall, 2-(2-Methoxyethoxy)ethyl methacrylate is a valuable tool for researchers working in various fields, particularly those focused on developing new materials for biomedical applications.**
2-(2-methoxyethoxy)ethyl methacrylate: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 170752 |
| SCHEMBL ID | 65472 |
| MeSH ID | M0534052 |
Synonyms (34)
| Synonym |
|---|
| di(ethylene glycol) methyl ether methacrylate, 95% |
| diethylene glycol monomethyl ether methacrylate |
| FT-0691206 |
| methyl carbitol methacrylate |
| methacrylic acid 2-(2-methoxyethoxy)ethyl ester |
| 45103-58-0 |
| 2-(2-methoxyethoxy)ethyl methacrylate |
| D1531 |
| 2-(2-methoxyethoxy)ethyl 2-methylprop-2-enoate |
| mdm cpd |
| methoxydiglycol methacrylate |
| einecs 256-190-2 |
| unii-0548t81dso |
| 0548t81dso , |
| AKOS015966709 |
| di(ethylene glycol) methyl ether methacrylate |
| nk ester m 20g |
| blemmer pme 100 |
| methoxydiglycol methacrylate [inci] |
| methoxyethoxyethyl methacrylate |
| SCHEMBL65472 |
| DTXSID8068464 |
| DAVVKEZTUOGEAK-UHFFFAOYSA-N |
| 2-(2-methoxyethoxy)ethyl 2-methylacrylate # |
| mfcd00059330 |
| diethylene glycol monomethyl ether methacrylate (stabilized with mehq) |
| diethylene glycol monomethyl ether methacrylate, (stabilized with mehq) |
| CS-0204643 |
| EN300-1704831 |
| Q27236076 |
| 2-(2-methoxyethoxy)ethylmethacrylate |
| VBA10358 |
| BS-22734 |
| STARBLD0018900 |
Research
Studies (9)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 20.86
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 20.86 (24.57) | | Research Supply Index | 2.30 (2.92) | | Research Growth Index | 5.53 (4.65) | | Search Engine Demand Index | 15.26 (26.88) | | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |